A vs OMCL: fair value comparison
Agilent Technologies, Inc. and Omnicell, Inc. · Updated 2026-09-06
A currently screens as fairly valued while OMCL screens as undervalued. Within Healthcare, OMCL currently sits closer to the top of our discount ranking. A carries the stronger quality grade.
| A | OMCL | |
|---|---|---|
| Verdict | Fairly valued | Undervalued |
| Last price | $150.86 | $37.65 |
| 12-month range | $114.52–$150.10 | $29.96–$48.70 |
| Sector rank | #59 of 113 Healthcare | #54 of 113 Healthcare |
| Quality grade | C | D |
| Leverage | Moderate | Low |
| Margin trend | Contracting | — |
| Revenue growth | Declining | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Downtrend |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: A fair value analysis · OMCL fair value analysis